SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-190938
Filing Date
2022-07-11
Accepted
2022-07-11 08:30:32
Documents
14
Period of Report
2022-07-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d663956d8k.htm   iXBRL 8-K 26504
2 EX-99.1 d663956dex991.htm EX-99.1 11501
6 GRAPHIC g663956img.jpg GRAPHIC 6907
  Complete submission text file 0001193125-22-190938.txt   170962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20220708.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20220708_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20220708_pre.xml EX-101.PRE 10823
8 EXTRACTED XBRL INSTANCE DOCUMENT d663956d8k_htm.xml XML 3225
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 221075919
SIC: 3841 Surgical & Medical Instruments & Apparatus